Talbot, Toby
Mayo Clinic
Arnaud Scherpereel, MD, PhD, CHU Lille, Univ. Lille, Inserm, U1366-UMR9020-CRCLille-Cancer Research Center of Lille, OncoThAI, ONCOLille, Lille, France; Aaron S. Mansfield, MD, Mayo Clinic, Rochester, MN; Francesco Grossi, MD; Medical Oncology Division, De
Citations 1
Reply to: “Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743” and “Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743”
Scherpereel, Arnaud , Mansfield, Aaron S. , Grossi, Francesco , Popat, Sanjay , Baas, Paul , Nowak, Anna K. , Tsao, Anne S. , Fujimoto, Nobukazu , Aragón, Yolanda Bautista, Talbot, Toby, Kaplan, Muhammet A., Soomro, Raheela, Hu, Nan , Ip, Virginia , Peters, Solange , Talbot, Toby , Kowalski, Dariusz , Cardona, Andrés F , Lee, Adam , Hung, Yu-Han , Zalcman, Gérard , Mansfield, Aaron S , Nowak, Anna K , Popat, Sanjay , Baas, Paul , Grossi, Francesco , Tsao, Anne S. , Peters, Solange , Bautista-Aragón, Yolanda, Kowalski, Dariusz M. , Cardona, Andrés F. , Zalcman, Gérard
Journal of Clinical Oncology | July 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
